NNC0662-0419 Clinical Trials (2026): 5 Studies for Obesity & Overweight
Hipa.ai Research · Source: ClinicalTrials.gov / AACT
Synced daily from ClinicalTrials.gov via AACT. Last sync: .
5 NNC0662-0419 clinical trials are catalogued on Hipa.ai from the AACT mirror of ClinicalTrials.gov, spanning 2 indications (including Obesity & Overweight) and 739 total planned enrollment. 2 NNC0662-0419 clinical trials are actively recruiting at 21 U.S. sites across 10 states. Most recent activity: NCT07415954 (Oct 2027).
Where to Participate: All NNC0662-0419 Trial Sites in the U.S. (21 sites across 10 states)
Every actively recruiting NNC0662-0419trial site, sorted by state then city. Each row links to the trial detail page (eligibility, contacts, full study record). Sites no longer enrolling at the location level are excluded. ClinicalTrials.gov / AACT does not provide street-level addresses; the map link uses the facility's geocoded coordinates where available.
| State | Facility | City | Trial | Map |
|---|---|---|---|---|
| CA | First Valley Medical Group | Lancaster93534 | NCT07415954 | Map |
| CA | Torrance Clinical Research Institute, Inc. | Lomita90717 | NCT07415954 | Map |
| CA | Ark Clinical Research | Long Beach90815 | NCT07415954 | Map |
| CA | Pacific Clinical Studies | Los Alamitos90720 | NCT07415954 | Map |
| CA | Wetlin Research Associates, Inc. | San Diego92120 | NCT07415954 | Map |
| CA | Diablo Clinical Research, Inc. | Walnut Creek94598 | NCT07415954 | Map |
| FL | Encore Medical Research LLC | Hollywood33024 | NCT07415954 | Map |
| FL | Bioclinical Research Alliance | Miami33155 | NCT07415954 | Map |
| FL | South Broward Research LLC | Miramar33027 | NCT07415954 | Map |
| FL | Encore Medical Research of Weston | Weston33331 | NCT07415954 | Map |
| ID | Elite Clinical Trials | Blackfoot83221 | NCT07415954 | Map |
| IL | Cedar-Crosse Research Center | Chicago60607 | NCT07415954 | Map |
| KS | Altasciences Clinical Kansas, Inc. | Overland Park66212 | NCT07525791 | Map |
| MO | Headlands Research | Springfield65807 | NCT07415954 | Map |
| NC | PharmQuest | Greensboro27408 | NCT07415954 | Map |
| NC | Piedmont Healthcare Statesville | Statesville28625 | NCT07415954 | Map |
| OH | Providence Center for Clinical Research | Dayton45439 | NCT07415954 | Map |
| TN | CNS Healthcare | Memphis38119 | NCT07415954 | Map |
| TX | University of Texas Southwestern Medical Center | Dallas75390-9302 | NCT07415954 | Map |
| TX | JCCT- Juno NW Houston | Houston77040 | NCT07415954 | Map |
| TX | Consano Clinical Research, LLC | Shavano Park78231 | NCT07415954 | Map |
NNC0662-0419 clinical trials at a glance: phase × recruitment status
| Phase | recruiting | active not recruiting | completed | Total |
|---|---|---|---|---|
| P1 | 1 | 2 | 3 | |
| P2 | 1 | 1 | 2 |
Recruiting NNC0662-0419 clinical trials (2)
Studies currently enrolling participants. Click any NCT ID to view the trial detail page (eligibility, sites, contacts).
| NCT ID | Title | Phase | Indication | Enrollment | Started |
|---|---|---|---|---|---|
| NCT07415954 | A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes | P2 | Diabetes Mellitus, Type 2 | 270 | Apr 2026 |
| NCT07525791 | A Research Study Looking Into How NNC0662-0419 Works With Birth Control Pills and Emptying of the Stomach in Women Not Able to Become Pregnant With Excess Body Weight | P1 | Overweight | 45 | Apr 2026 |
NNC0662-0419 clinical trials by indication
Overweight (4)
| NCT | Acronym | Phase | Status | Title |
|---|---|---|---|---|
| NCT07525791 | — | P1 | recruiting | A Research Study Looking Into How NNC0662-0419 Works With Birth Control Pills and Emptying of the Stomach in Women Not Able to Become Pregnant With Excess Body Weight |
| NCT07184632 | — | P2 | active not recruiting | A Research Study on How Well Different Doses of the Medicine NNC0662-0419 Help People Living With Overweight or Obesity |
| NCT07101783 | — | P1 | completed | A Research Study on How a Dose of NNC0662-0419 Works in Japanese, Chinese and Non-Asian Participants Living With Overweight or Obesity |
| NCT06737536 | — | P1 | completed | A First-in-human Research Study on How NNC0662-0419 Works in People Living With Overweight or Obesity |
Diabetes Mellitus, Type 2 (1)
| NCT | Acronym | Phase | Status | Title |
|---|---|---|---|---|
| NCT07415954 | — | P2 | recruiting | A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes |
All NNC0662-0419 trials (5)
Sorted by most recent activity (completion → start → posted date). Each row links to the trial detail page on Hipa.ai.
| NCT ID | Acronym | Title | Phase | Status | Enrollment | Sponsor | Started |
|---|---|---|---|---|---|---|---|
| NCT07415954 | A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes | P2 | recruiting | 270 | Novo Nordisk A/S | Apr 2026 | |
| NCT07525791 | A Research Study Looking Into How NNC0662-0419 Works With Birth Control Pills and Emptying of the Stomach in Women Not Able to Become Pregnant With Excess Body Weight | P1 | recruiting | 45 | Novo Nordisk A/S | Apr 2026 | |
| NCT07184632 | A Research Study on How Well Different Doses of the Medicine NNC0662-0419 Help People Living With Overweight or Obesity | P2 | active not recruiting | 224 | Novo Nordisk A/S | Oct 2025 | |
| NCT07101783 | A Research Study on How a Dose of NNC0662-0419 Works in Japanese, Chinese and Non-Asian Participants Living With Overweight or Obesity | P1 | completed | 100 | Novo Nordisk A/S | Aug 2025 | |
| NCT06737536 | A First-in-human Research Study on How NNC0662-0419 Works in People Living With Overweight or Obesity | P1 | completed | 100 | Novo Nordisk A/S | Dec 2024 |
NNC0662-0419 clinical trials: frequently asked questions
- How many NNC0662-0419 clinical trials are there?
- 5 NNC0662-0419 clinical trials are catalogued on Hipa.ai, sourced from the AACT mirror of ClinicalTrials.gov. 2 are actively recruiting participants. 2 are marked completed.
- Are NNC0662-0419 clinical trials recruiting in 2026?
- Yes — 2 NNC0662-0419 trials are actively recruiting in 2026, with 21 U.S. sites across 10 states. See the recruiting trials and the per-state site list further down this page.
- What conditions is NNC0662-0419 being studied for?
- NNC0662-0419 is being studied for Obesity, Overweight, Diabetes Mellitus, Type 2. The trials are grouped by indication on this page.
- What phase is NNC0662-0419 in?
- NNC0662-0419 clinical trials span 2 Phase 2, 3 Phase 1. The phase × status matrix at the top of this page breaks down counts by phase and recruitment status.
- Who sponsors NNC0662-0419 clinical trials?
- The lead sponsor across the most NNC0662-0419 trials is Novo Nordisk A/S. Each trial row links to the full study detail page including sponsor information.
Sources and methodology
Trial inventory derived from the AACT mirror of ClinicalTrials.gov. Trials are filtered to those naming NNC0662-0419as an intervention. Phase, status, enrollment, sponsor, and dates are taken from the source `studies` table; primary indication is the first listed condition. Acronyms are extracted from each trial's brief title where present. PubMed links are populated for trials whose published primary outcomes have been indexed in our evidence cache.
Last refreshed .
Related pages on Hipa.ai: